Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

New MS Therapies Show Promise


Related Encyclopedia
 border=
Acoustic Neurinoma
Bell's Palsy
Brain and Spinal Cord Magnetic Resonance Imaging
Brain Tumors
More...

Related Healthscout Videos
 border=
Prime Time
New Drugs That Could Stop MS
New Therapy for Stroke Patients
Mapping the Brain     
More...

Related Drug Information
 border=
Adderal XR
Concerta
Coumadin
Depakote
More...

Related News Articles
 border=
Retrovirus May Be at Root of Chronic Fatigue Syndrome
Early Drug Treatment May Cut Multiple Sclerosis Risk
Potential Pieces of Autism Puzzle Revealed
Autism May Be More Common Than Thought
More...


Page:  << Prev | 1 | 2 | 3

Alemtuzumab reduced by 74 percent the risk of MS relapse, the researchers reported in the Oct. 23 issue of the New England Journal of Medicine.

"The ability of an MS drug to promote brain repair is unprecedented," Alasdair Coles, of Cambridge University in England, and one of the study's leaders, told the AFP news service. "We are witnessing a drug which, if given early enough, might effectively stop the advancement of the disease and also restore lost function by promoting repair of the damaged brain tissue."

However, in an accompanying journal editorial, Dr. Stephen L. Hauser, a neurologist at the University of California, San Francisco, said the "toxic effects associated with alemtuzumab considerably dampen any enthusiasm for its routine use in patients with multiple sclerosis until more is known about its long-term safety and sustained efficacy."

Text Continues Below



More information

The U.S. National Institute of Neurological Disorders and Stroke has more about multiple sclerosis.

Page:  << Prev | 1 | 2 | 3

-- Robert Preidt

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 10/24/2008

Related Links
 border=
From Healthscout's partner site on chronic pain, ChronicPainConnection.com
Find ways to get chronic pain relief!
Find a right treatment for your chronic pain
Join our community - your chronic pain support group.





SOURCE: The Lancet, news release, Oct. 23, 2008; New England Journal of Medicine, Oct. 23, 2008


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy